HIV / AIDS in the News

Breakthrough: Theratechnologies HIV Treatment Matches Standard Care in Challenging Cases - StockTitan

 

Groundbreaking Research Shows BMI Misses Critical Heart Risks in 43% of HIV Patients - StockTitan

 

Half the men in an HIV cure study stayed off treatment for nearly a year after a two-antibody shot - aidsmap

 

Vivent Health: Is raising funds to provide medication and care to Milwaukeeans with HIV - Wisbusiness.com

 

Risk Factors Among HIV Seropositive Cases Attending a Tertiary Care Hospital of a North-Eastern State of India: A Hospital-Based Retrospective Cross-Sectional Study - Cureus

 

Strengthening the delivery of HIV testing services for elimination of mother-to-child transmission - World Health Organization

 

'HIV 101' teacher wins award for imparting 'it's not something to be ashamed of' - Pittsburgh Post-Gazette

 

Yearly HIV prevention injection shows promise in clinical trial - Deccan Herald

 

Advancing HIV response and human rights: a timeline of ILGA World’s advocacy work - International Lesbian, Gay, Bisexual, Trans and Intersex Association

 

Two more people with HIV may be cured after stem cell transplants - aidsmap

 

Radical changes in US policy threaten two decades’ progress in HIV - aidsmap

 

PEPFAR study shows the deadly impact of stopping children’s HIV treatment - aidsmap

 

Ending HIV requires changing how we talk – or don’t talk – about PrEP - STAT

 

Yearly HIV prevention injection 'Lenacapavir' shows promise in clinical trial - The New Indian Express

 

Single-Tablet ART Regimen of DOR/ISL Effective for HIV Virologic Suppression - Infectious Disease Advisor

 

Leading HIV advocate David Polson farewelled at state funeral in Sydney - ABC News

 

“Magic” for Those Who Can’t Take Pills: Groundbreaking HIV Treatment Achieves 98% Viral Suppression - SciTechDaily

 

Public Health hosts annual ‘Rocking our Red Pumps’ event to raise HIV awareness - WHIO

 

Why a Holistic Approach to HIV and Menopause Matters - AJMC.com Managed Markets Network

 

First-of-its-kind annual HIV shot moves closer to reality, passes key trial - Interesting Engineering

 

ViiV releases promising phase 2 data on potential long-acting HIV drugs - Seeking Alpha

 

‘Act Up. Fight Back.’ Hundreds of Scientists and Clinicians Protest Funding Cuts - Infectious Disease Special Edition

 

HIV Education and Advocacy in an Age of Uncertainty - Contagionlive.com

 

Twiggs County Health Dept. offers free testing for Women and Girls HIV, AIDS Awareness Day - wgxa.tv

 

Sex advice: My boyfriend tested positive for HIV. I'm afraid I'm staying out of pure obligation. - Slate

 

New data shows Philadelphia’s HIV rates, showing how far we’ve come and where we’re heading - Philadelphia Gay News

 

Gilead plots trial of groundbreaking, once-a-year HIV prevention drug lenacapavir - The Business Journals

 

HIV and Long COVID Insights from the RECOVER Program on Risk and Diagnosis - Contagionlive.com

 

Gilead's Once-Yearly Lenacapavir Formulations Show Sustained Efficacy for HIV PrEP in Phase 1 Study - Contagionlive.com

 

ViiV Healthcare showcases leadership in long-acting injectables innovation at CROI 2025 with data on third-generation integrase inhibitor (INSTI) and highly potent capsid inhibitor against HIV-1 - Business Wire